Azaleatin
Based on 1 Customer Validation
Azaleatin is an orally active inhibitor of hQC, NS2B-NS3 protease and E. coli β-glucuronidase, with IC50 values of 1.1 μM, 38.00 μg/mL and 0.57 μM, respectively. Azaleatin inhibits the activities of NF-κB, MyD88, JAK1, TLR4, STAT3, IL-1β, IL-6, COX-2, TNF-α and β-glucuronidase, blocks pro-inflammatory signaling pathways, reduces the levels of ROS, MDA and uric acid, elevates the levels of GPx, GSR, GST, SOD, CAT, HO-1 and GSH, scavenges free radicals and exerts reducing capacity. Azaleatin inhibits the expression of pro-apoptotic proteins Bax, Caspase-9 and Caspase-3, and upregulates the expression of anti-apoptotic protein Bcl-2. Azaleatin reduces the levels of cardiac injury markers, restores cardiac histological structure, inhibits Aβ aggregation, dengue protease activity, hepatic stellate cell proliferation and cancer cell growth, and also exhibits antibacterial activity. Azaleatin can be used in studies related to subchronic cardiotoxicity, Alzheimer's disease, dengue fever, hyperuricemia, liver fibrosis, gastric cancer and bacterial infections.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98.86%
- CAS No.: 529-51-1
- Formule: C16H12O7
- Masse moléculaire:316.26
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Voir tous les produits spécifiques à Isoform Caspase
More
Activité biologique
Description
|
DPP-4 |
JAK1 |
TLR4 |
STAT3 |
IL-6 |
IL-1β |
COX-2 |
hQC 1.1 μM (IC50) |
hQC 0.4 nM (Kd) |
GSR |
GST |
Caspase-9 |
Caspase-3 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | IC50 |
0.74 μM
Compound: 7b
|
Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay
Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay
|
[PMID: 20731357] |
In Vitro
Azaleatin binds strongly to NF-κB, TLR4, and STAT3 proteins, with the highest affinity for NF-κB (-8.5 kcal/mol), indicating its potential to regulate pro-inflammatory signaling pathways[1].
Azaleatin (multiple concentrations; 5 min) potently inhibits human glutaminyl cyclase (hQC) in biochemical assays, with an IC50 of 1.1 μM[2].
Azaleatin (12.5-100 μM) binds to purified human glutaminyl cyclase (hQC) with high affinity, and its KD is determined to be 0.4 nM by surface plasmon resonance[2].
Azaleatin binds to the active site of human glutaminyl cyclase (hQC) via coordination with catalytic zinc ions, hydrogen bonding, anion-π interactions, and hydrophobic interactions with key residues, thereby supporting its inhibitory activity[2].
Azaleatin complies with Lipinski's Rule of Five and possesses favorable pharmacokinetic properties, including good absorbability, non-carcinogenicity, and higher bioavailability compared with quercetin[3].
Azaleatin binds to the central active site of β-glucuronidase (PDB ID: 3K4D) with a binding affinity of -8.5 kcal/mol, and forms polar and hydrophobic interactions with key enzyme residues[4].
Azaleatin forms a stable complex with β-glucuronidase (PDB ID: 3K4D) during a 50 ns MD simulation, exhibiting characteristics of strong electrostatic interactions, stable hydrogen bonding, and reduced enzyme flexibility, which is consistent with its potent in vitro inhibitory activity[4].
Azaleatin (10-30 μM; 2 h) inhibits uric acid production in a concentration-dependent manner in AML12 hepatocytes[5].
Azaleatin (5-80 μM; 6-24 h) inhibits the proliferation of rat hepatic stellate cells (HSC-T6) at a concentration of 80 μM after 24 h of incubation; it promotes cell proliferation in a dose-dependent manner at 6 h, while exerts no effect at low doses within 12 h[6].
Azaleatin (20-40 μM; 24 h) reduces αSMA accumulation in a dose-dependent manner, and effectively inhibits TGFβ-induced type I collagen production in rat hepatic stellate cells (HSC-T6) after 24 h of co-treatment at concentrations of 20 μM and 40 μM[6].
Azaleatin (20 μM; 1-6 h) does not inhibit TGFβ-induced αSMA or Timp1 mRNA expression, but reduces type I collagen mRNA expression in a time-dependent manner in TGFβ-induced rat hepatic stellate cells (HSC-T6) after 6 hours of co-treatment at a concentration of 20 μM[6].
Azaleatin (5-1,000 μg/mL) exhibits in vitro antioxidant activity by scavenging DPPH, superoxide anion and hydroxyl radicals, as well as through its reducing capacity, but shows no metal chelating activity, with EC50 values of 37 μg/mL (DPPH), 90 μg/mL (superoxide anion), 688 μg/mL (hydroxyl radical) and 27 μg/mL (reducing capacity)[7].
Azaleatin is present in the ethanol extract of *Rhododendron anthopogonoides*, and its content is determined to be 0.10 mg/g fresh weight via UPLC quantitative analysis[7].
Azaleatin (5 mg) exists as its 3-O-α-L-rhamnoside derivative (azaleatin-3-O-α-L-rhamnoside) in the ethanolic fruit extract of *Azara dentata*. This compound is identified via UHPLC-ESI-Q-TOF-MS, with a pseudomolecular ion m/z value of 461.1064, corresponding to the product ion m/z value of 287.0555 for azaleatin-3-O-α-L-rhamnoside[8].
Azaleatin (3.125-200 μg/mL; 20-100 μg/mL) acts as a non-competitive inhibitor against dengue NS2B-NS3 serotype 2 protease, with an IC50 of 38 μg/mL and a Ki of 26.82 μg/mL[3].
Azaleatin binds to the allosteric pocket of dengue virus NS2B-NS3 protease (PDB ID: 3U1I) with a docking score of -8.2 kcal/mol, and forms hydrogen bonds and hydrophobic interactions with key functional residues[3].
Azaleatin (100 ns) forms a stable complex with dengue virus NS2B-NS3 protease (PDB ID: 3U1I) during the 100 ns simulation, stabilizes the closed conformation of this enzyme, and supports its non-competitive inhibition mode[3].
Azaleatin (0.001-1000 μM; 30 min) potently inhibits Escherichia coli β-glucuronidase via a non-competitive mechanism, with an IC50 of 0.57 μM and a Ki of 0.66 μM[4].
Azaleatin (10-250 μM; 48 h) inhibits the viability of HGC-27 cells. Its significant growth-inhibitory effect emerges starting at 10 μM, and cell viability drops to approximately 40% of that in the control group at the highest tested concentration. Among the three flavonoids tested, it exhibits the weakest cell growth inhibitory activity[9].
Azaleatin (20-35 μM; 24 h) significantly increases pentoside levels in HGC-27 cells at concentrations of 20 μM and above following 24 h of incubation. It exhibits moderate potency, which is higher than that of kaempferol but lower than that of myricetin[9].
Azaleatin (15-35 μM; 24 h) induces a dose-dependent increase in 3-deoxyglucosone levels in HGC-27 cells, with a significant elevation starting at 15 μM and reaching 2.5 times the control level at the highest tested concentration. Among the tested flavonoids, it exhibits the weakest effect on this indicator[9].
Azaleatin (5-35 μM; 24 h) potently elevates methylglyoxal levels in HGC-27 cells, with an initial effective concentration of 5 μM. At the highest tested concentration, the methylglyoxal level reaches approximately 3.3 times that of the control group. In terms of this indicator, its efficacy is far superior to that of other tested flavonoid compounds[9].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HSC-T6 (rat hepatic stellate cells)
-
Concentration:5, 10, 20, 40 and 80 μM
-
Incubation Time:6, 12 and 24 h
-
Result:Increased HSC-T6 proliferation in a dose-dependent manner after 6 h treatment.
Decreased proliferation to levels comparable to non-treated controls after 12 h treatment.
Markedly suppressed HSC-T6 proliferation at 80 μM after 24 h incubation; no inhibitory effect was observed at lower doses (5, 10, 20, 40 μM) up to 12 h.
-
Cell Line:HSC-T6 (TGFβ-induced rat hepatic stellate cells)
-
Concentration:20 and 40 μM
-
Incubation Time:24 h
-
Result:Reduced αSMA accumulation compared to TGFβ-induced positive controls, with dose-dependent enhancement from 20 μM to 40 μM; the inhibitory effect was weaker than other methylated quercetin derivatives.
Effectively inhibited collagen I production in TGFβ-induced HSC-T6 cells.
-
Cell Line:HSC-T6 (TGFβ-induced rat hepatic stellate cells)
-
Concentration:20 μM
-
Incubation Time:1 and 6 h
-
Result:Did not inhibit TGFβ-induced augmentation of αSMA mRNA after 1 h co-treatment.
Decreased αSMA mRNA levels after 6 h co-treatment, though levels remained higher than non-treated controls.
Increased collagen I mRNA after 1 h co-treatment but decreased it after 6 h in a time-dependent manner.
Did not inhibit TGFβ-induced increases in Timp1 mRNA expression after 6 h co-treatment.
-
Cell Line:HGC-27 immortalised human-stomach adenocarcinoma cells
-
Concentration:0, 50, 100, 150, 200 and 250 μM
-
Incubation Time:48 h
-
Result:Significantly inhibited HGC-27 cell growth starting at 10 μM.
Reduced cell viability to approximately 40% of control at the highest tested concentration.
Ranked as the least effective cell growth inhibitor among kaempferol, myricetin, and azaleatin.
-
Cell Line:AML12 cells
-
Concentration:0, 3, 10 and 30 μM
-
Incubation Time:2 h
-
Result:Significantly and dose-dependently decreased the uric acid production in the hepatocytes.
At dose of 3 μM did not inhibit uric acid production.
At 10 μM significantly suppressed uric acid production.
At 30 μM significantly suppressed uric acid production .
Showed more notable inhibitory effect at 30 μM than that at lower concentrations.
In Vivo
Azaleatin (25 mg/kg; p.o.; daily; 8 weeks) is well-tolerated and does not induce adverse cardiac effects in healthy male Sprague Dawley rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Sprague-Dawley rats (13-14 weeks old, 225 g) were orally administered sodium arsenite (10 mg/kg) for 8 weeks to induce myocardial injury. Meanwhile, the compound was orally administered to evaluate its cardioprotective effects.
[1] -
Dosage:25 mg/kg
-
Administration:p.o.; daily; 8 weeks
-
Result:Significantly downregulated mRNA expressions of pro-inflammatory genes (NF-κB, MyD88, JAK1, TLR4, STAT3, IL-6, IL-1β, TNF-α) to levels not significantly different from the control group.
Restored cardiac antioxidant enzyme activities: catalase (CAT) increased from 2.27 U/mg protein to 8.50 U/mg protein; superoxide dismutase (SOD) increased from 2.02 U/mg protein to 5.47 U/mg protein; glutathione reductase (GSR) increased from 2.48 nM NADPH oxidized/min/mg tissue to 5.24 nM NADPH oxidized/min/mg tissue; glutathione peroxidase (GPx) increased from 3.49 U/mg protein to 11.81 U/mg protein; glutathione (GSH) increased from 3.06 μmol/g tissue to 9.37 μmol/g tissue; glutathione S-transferase (GST) increased from 4.28 U/mg protein to 14.92 U/mg protein; heme-oxygenase-1 (HO-1) increased from 68.58 pmoles bilirubin/mg protein/h to 231.18 pmoles bilirubin/mg protein/h.
Reduced oxidative stress markers: malondialdehyde (MDA) decreased from 13.61 nmol/g to 5.09 nmol/g; reactive oxygen species (ROS) decreased from 13.28 nmol/g to 4.47 nmol/g.
Reduced cardiac injury marker levels: CK-MB decreased from 83.05 ng/mL to 47.02 ng/mL; CPK decreased from 491.67 mcg/L to 273.89 mcg/L; troponin-I decreased from 5.89 pg/mL to 2.33 pg/mL; troponin-T decreased from 3.67 ng/mL to 1.59 ng/mL; LDH decreased from 42.10 mg/mL to 20.63 mg/mL; BNP decreased from 78.75 pg/mL to 40.89 pg/mL; NT-proBNP decreased from 316.73 pg/mL to 178.14 pg/mL; CRP decreased from 19.38 mg/L to 10.91 mg/L.
Modulated apoptotic markers: Bax decreased from 15.15 pg/mL to 4.97 pg/mL; caspase-9 decreased from 14.19 pg/mL to 6.46 pg/mL; caspase-3 decreased from 12.81 pg/mL to 3.43 pg/mL; Bcl-2 increased from 3.84 ng/mL to 8.34 ng/mL.
Prevented sodium arsenite-induced cardiac damage (myofiber degeneration, hypertrophy, vascular congestion, edema, hemorrhage, inflammation, dysregulated intercalated discs), preserving near-normal cardiac architecture.
Showed values for all measured parameters comparable to the control group in the azaleatin-only group, indicating a safe profile at the tested dose.
-
Animal Model:Sprague Dawley (male, 13-14 weeks old, 225 g)[1]
-
Dosage:25 mg/kg
-
Administration:p.o.; 8 weeks
-
Result:Resulted in mRNA expressions of pro-inflammatory genes (NF-κB, MyD88, JAK1, TLR4, STAT3, IL-6, IL-1β, TNF-α), antioxidant enzyme activities, oxidative stress marker levels, cardiac injury marker levels, apoptotic marker levels, and cardiac histology that were all comparable to the control group, with no significant differences detected.
Chemical Information
-
CAS No. 529-51-1
-
Appearance Solid
-
Masse moléculaire 316.26
-
Formule C16H12O7
-
Color Off-white to light yellow
-
SMILES
O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC3=CC(O)=CC(OC)=C13
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
In Vitro:
DMSO : 50 mg/mL (158.10 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1.25 mg/mL (3.95 mM); Clear solution
This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 1.25 mg/mL (3.95 mM); Clear solution
This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocole
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Collagen: Sirius Red Staining
Sirius Red or picrosirius red staining is a histochemical method for visualizing collagen-rich extracellular matrix in tissue sections, and collagen fibers are detected as red-stained structures under bright-field microscopy with enhanced birefringence under polarized light. Picrosirius red is useful for assessing total collagen organization, distribution, and fibrosis burden, but polarized color should not be interpreted as a definitive collagen type I versus type III readout because color is affected by fiber orientation, thickness, and packing.
-
Somatic Cell Culture
A method of simulating the in vivo environment in vitro to maintain the cell growth, differentation and main functions.
-
Connective Tissue: Masson's Trichrome/Collagen Trichrome Staining
Masson’s Trichrome (collagen/trichrome staining) is a histological technique that differentially stains tissue compartments using sequential acidic dyes to distinguish collagen from muscle and cytoplasmic components based on dye affinity and tissue permeability differences, enabling visualization of fibrosis and connective tissue architecture in histological sections. The classical formulation typically uses Weigert's iron hematoxylin for nuclear staining, Biebrich scarlet-acid fuchsin for cytoplasm and muscle, and aniline blue (or light green variants) for collagen, producing a characteristic blue/green collagen signal contrasted against red cytoplasm and dark nuclei. The staining principle relies on selective displacement of smaller dye molecules by larger anionic dyes in collagen-rich regions under controlled acidified conditions, which enhances collagen-specific dye retention. This property makes the method widely used for fibrosis assessment in organs such as heart, liver, lung, a
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
CFSE Dye Dilution Proliferation Assay
The CFSE (carboxyfluorescein diacetate succinimidyl ester) dye dilution proliferation assay is based on the covalent labeling of intracellular proteins by a cell-permeant fluorescent dye that becomes fluorescent upon intracellular ester cleavage and then is stably retained within cells. As labeled cells divide, the dye is partitioned equally between daughter cells, resulting in a stepwise halving of fluorescence intensity that can be quantified by flow cytometry to determine the number of cell divisions undergone by each cell population. This fluorescence dilution approach enables quantitative tracking of lymphocyte proliferation at the single-cell level over multiple rounds of division. CFSE-based proliferation analysis has been widely applied to measure antigen-driven lymphocyte expansion in vitro, where discrete fluorescence peaks correspond to successive cell divisions and allow reconstruction of proliferative history within heterogeneous populations.
-
Dye-dilution cell tracking and proliferation staining
Dye-dilution cell tracking assays quantify cell proliferation by covalently labeling intracellular proteins with a stable fluorescent dye that is equally partitioned between daughter cells during mitosis, resulting in stepwise halving of fluorescence intensity with each cell division as measured by flow cytometry histograms. Carboxyfluorescein diacetate succinimidyl ester (CFSE) is a prototypical dye that diffuses into cells, is enzymatically converted into a fluorescent compound, and then covalently binds intracellular amine groups, producing long-lived fluorescence suitable for tracking multiple rounds of division in vitro and in vivo. Successive generations of dividing cells form discrete peaks of decreasing fluorescence intensity, enabling estimation of proliferation history, precursor frequency, and division index within heterogeneous populations. Alternative dyes such as CellTrace Violet (CTV) and far-red membrane dyes (e. g. , PKH26) follow the same dilution principle but differ
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Cell Counting-Based Growth Curve Assay
Cell counting-based growth curve assays quantify cell proliferation by directly measuring changes in viable cell number over time using manual or automated counting methods such as hemocytometer-based counting or instrument-assisted cell enumeration, enabling construction of growth curves that reflect population expansion dynamics in response to culture conditions. A widely used approach is trypan blue exclusion with hemocytometer counting, where membrane-compromised (non-viable) cells take up the dye, allowing discrimination between viable and non-viable cells while simultaneously enabling total cell number quantification. Repeated sampling across time points allows estimation of proliferation rate, growth phases, and comparative growth kinetics between experimental conditions.
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Liver Histomorphometry
Liver histomorphometry is a quantitative histological approach used to measure structural alterations in hepatic tissue, including parenchymal loss, steatosis, fibrosis, and vascular remodeling, by combining stained tissue section analysis with stereological or computerized image-based measurements. Classical morphometric frameworks quantify volume fractions of liver compartments and fibrotic regions using systematic sampling and image analysis, enabling objective comparison of pathological changes across experimental groups. These approaches are widely applied in liver cirrhosis and fibrosis studies to reduce subjectivity in histological scoring and improve reproducibility of tissue evaluation. Recent methodological advances integrate automated image analysis and radiomics-based extraction of histological features from standard liver stains (e. g. , H&E and fibrotic stains), enabling quantitative correlation between morphometric features and fibrosis stages in non-alcoholic fatty live
-
Fibrosis/Collagen Morphometry
Fibrosis and collagen morphometry is based on the quantitative visualization of fibrillar collagen deposition in tissue sections using histochemical stains such as Sirius Red (Picrosirius Red) or Masson's trichrome, followed by image-based or polarization-enhanced analysis to estimate collagen proportional area as a surrogate of extracellular matrix accumulation during fibrotic remodeling. Sirius Red combined with polarized light microscopy enhances detection of collagen fibers due to birefringence properties, enabling more specific visualization of collagen type I and III fibrils compared to conventional bright-field histology, while whole-section or region-restricted digital morphometry reduces field-selection bias in fibrosis assessment. Alternative quantitative approaches include second harmonic generation (SHG) and two-photon excited fluorescence microscopy, which enable label-free detection of fibrillar collagen and have been validated against histological staining and biochemica
-
EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
The EdU incorporation assay measures DNA synthesis by adding the thymidine analog 5-ethynyl-2′-deoxyuridine to cells or tissues, where it is incorporated into newly synthesized DNA during S phase. Incorporated EdU is detected by copper-catalyzed azide-alkyne cycloaddition, in which a fluorescent azide covalently reacts with the ethynyl group on EdU, allowing S-phase cells to be detected by fluorescence microscopy, flow cytometry, or high-content imaging. EdU detection does not require DNA denaturation or anti-BrdU antibody access, which preserves sample structure and improves compatibility with immunostaining and multiparameter cytometry compared with BrdU-based detection. EdU can be cytotoxic in a cell-type- and exposure-dependent manner, so pulse duration, concentration, and continuous-labeling designs should be validated for each cell type.
-
Ki-67 Immunostaining Proliferation Assay
Ki-67 immunostaining measures the growth fraction of a cell population by detecting Ki-67, a nuclear antigen present in proliferating cells and absent in quiescent G0 cells. The readout is the percentage of Ki-67-positive nuclei among total counted cells, commonly called the Ki-67 labeling index or proliferation index.
-
PCNA Immunodetection Proliferation Assay
PCNA immunodetection measures proliferative activity by detecting proliferating cell nuclear antigen, a nuclear protein associated with DNA polymerase δ function and DNA replication. The assay readout is the proportion of PCNA-positive nuclei among total counted cells, but PCNA labeling is not identical to BrdU labeling because PCNA can mark late G1/early S-associated replication competence and may persist beyond active DNA synthesis depending on fixation and extraction conditions.
-
Protocol for Cell Counting and Cell Density Analysis
Cell counting and cell-density analysis estimate the number of cells in a known volume or field area. Manual hemocytometer counting uses a chamber of defined geometry to convert counted cells into cells/mL, while automated counters and image-analysis workflows detect cell objects from optical, brightfield, fluorescence, impedance, or digital-image features. Trypan blue viability counting is based on dye exclusion: viable cells with intact membranes exclude dye, while non-viable cells with compromised membranes stain blue. The readout is total cell density, viable-cell density, dead-cell density, and percent viability. Cell density can also be estimated from microscopy images by counting objects per image area, from flow cytometry using calibrated volume or reference particles, or from in situ microscopy in bioreactors after calibration against reference methods such as hemocytometer or flow cytometry.
Pureté et documentation
-
Fiche technique (309 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Hassan HM, et al. Cardioprotective potential of azaleatin against sodium arsenite instigated sub-chronic cardiotoxicity via targeting TLR4/MyD88, JAK1/STAT3, and NF-κB in Sprague Dawley rats. J Trace Elem Med Biol. 2025;92:127763. [Content Brief]
[2]. Tsai KC, et al. Pharmacophore-driven identification of human glutaminyl cyclase inhibitors from foods, plants and herbs unveils the bioactive property and potential of Azaleatin in the treatment of Alzheimer's disease. Food Funct. 2022;13(24):12632-12647. Published 2022 Dec 13. [Content Brief]
[3]. Mustafa NF, Cheng KK, Nadri MH, Razali SA, Zakaria II, Salin NH, Amran SI. Discovery of azaleatin as a potential allosteric inhibitor for dengue NS2B-NS3 protease using in vitro and in silico studies. Journal of Biomolecular Structure and Dynamics. 2025 Sep 22;43(14):7759-70. [Content Brief]
[4]. Kamel EM, et al. Deciphering molecular mechanisms underlying the inhibition of β-glucuronidase by xanthones from Centaurium spicatum. Bioorg Chem. 2024;150:107609. [Content Brief]
[5]. Adachi SI, et al. Anti-hyperuricemic effect of isorhamnetin in cultured hepatocytes and model mice: structure-activity relationships of methylquercetins as inhibitors of uric acid production. Cytotechnology. 2019;71(1):181-192. [Content Brief]
[6]. Ganbold M, et al. Antifibrotic effect of methylated quercetin derivatives on TGFβ-induced hepatic stellate cells. Biochem Biophys Rep. 2019;20:100678. Published 2019 Aug 16. [Content Brief]
[7]. Dai L, He J, Miao X, Guo X, Shang X, Wang W, Li B, Wang Y, Pan H, Zhang J. Multiple biological activities of Rhododendron przewalskii Maxim. extracts and UPLC-ESI-Q-TOF/MS characterization of their phytochemical composition. Frontiers in Pharmacology. 2021 Feb 10;12:599778. [Content Brief]
[8]. Ramos LC, Palacios J, Barrientos RE, Gómez J, Castagnini JM, Barba FJ, Tapia A, Paredes A, Cifuentes F, Simirgiotis MJ. UHPLC-MS phenolic fingerprinting, aorta endothelium relaxation effect, antioxidant, and enzyme inhibition activities of azara dentata ruiz & pav berries. Foods. 2023 Feb 2;12(3):643. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.1620 mL | 15.8098 mL | 31.6196 mL | 79.0489 mL |
| 5 mM | 0.6324 mL | 3.1620 mL | 6.3239 mL | 15.8098 mL | |
| 10 mM | 0.3162 mL | 1.5810 mL | 3.1620 mL | 7.9049 mL | |
| 15 mM | 0.2108 mL | 1.0540 mL | 2.1080 mL | 5.2699 mL | |
| 20 mM | 0.1581 mL | 0.7905 mL | 1.5810 mL | 3.9524 mL | |
| 25 mM | 0.1265 mL | 0.6324 mL | 1.2648 mL | 3.1620 mL | |
| 30 mM | 0.1054 mL | 0.5270 mL | 1.0540 mL | 2.6350 mL | |
| 40 mM | 0.0790 mL | 0.3952 mL | 0.7905 mL | 1.9762 mL | |
| 50 mM | 0.0632 mL | 0.3162 mL | 0.6324 mL | 1.5810 mL | |
| 60 mM | 0.0527 mL | 0.2635 mL | 0.5270 mL | 1.3175 mL | |
| 80 mM | 0.0395 mL | 0.1976 mL | 0.3952 mL | 0.9881 mL | |
| 100 mM | 0.0316 mL | 0.1581 mL | 0.3162 mL | 0.7905 mL |
Keywords
- Azaleatin
- 529-51-1
- Dipeptidyl Peptidase
- NF-κB
- MyD88
- JAK
- Toll-like Receptor (TLR)
- STAT
- Interleukin Related
- COX
- Reactive Oxygen Species (ROS)
- Glutathione S-transferase
- SOD
- Bcl-2 Family
- Caspase
- Apoptosis
- Dengue Virus
- HSC-T6
- human glutaminyl cyclase
- Staphylococcus aureus
- TLR4
- Alzheimer’s disease
- Escherichia coli
- HGC-27
- STAT3
- dengue NS2B-NS3 protease
- Inhibitor
- inhibitor
- inhibit